As the U.S. stock market experiences fluctuations driven by rising Treasury yields and mixed economic data, investors are closely monitoring opportunities that may arise from these shifts. In this ...

Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate's latest ...

Finbold has selected three interesting pharmaceutical stocks that could see significant moves to the upside in 2025.

SHENZHEN — The South China metropolis of Shenzhen, Guangdong province, recently hosted a series of exhibitions, attracting ...

Neither coffee drinking pattern was tied to more or less cancer-specific mortality.

In the latest trading session, Eli Lilly (LLY) closed at $773.29, marking a +1.07% move from the previous day.

When, like Lilly Palmer as DJ has both the command of the room and the capacity to build an attractive set there's only one way this can go and that's bigger at 150 BPM.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

North Dakota lawmakers on Thursday will hear testimony on a bill to lower the price of insulin drugs and supplies for ...

The New York company is hoping to enter the GLP-1RA space with its newest offering requiring dosing every month over competitors’ more frequent regimens.

New FDA draft guidance for drugmakers focuses on trial design for developing obesity treatments. Read more here.

Summit Partners has hired Ricardo Gonzalez as a partner on the firm’s growth products and services team.